Genscript Biotech Corporation Free Cash Flow Generation Index
Genscript Biotech Corporation free cash flow generation index. Genscript Biotech Corporation (G51) has a Free Cash Flow Generation Index of 1.00x as of December 2019. Free cash flow of €61.62 Million represents 1% of operating cash flow (€61.62 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Genscript Biotech Corporation (2016–2025)
Free cash flow generation index of Genscript Biotech Corporation from 2016 to 2025. Historical FCF Generation Index trend for Genscript Biotech Corporation across 5 annual periods. See G51 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Genscript Biotech Corporation Free Cash Flow Generation Index by Year (2016–2025)
Genscript Biotech Corporation free cash flow generation index by year from 2016 to 2025. Year-by-year Free Cash Flow Generation Index for Genscript Biotech Corporation. For the full cash flow conversion analysis, see Genscript Biotech Corporation (G51) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €241.69 Million | €325.52 Million | €83.84 Million | ▲ +177.7% |
| 2024 | -0.96x | €-72.27 Million | €75.65 Million | €147.92 Million | ▼ -236.2% |
| 2018 | 0.70x | €215.80 Million | €307.66 Million | €70.84 Million | ▲ +241.4% |
| 2017 | -0.50x | €-10.60 Million | €21.37 Million | €29.21 Million | ▼ -139.1% |
| 2016 | 1.27x | €42.26 Million | €33.27 Million | €8.98 Million | — |